AIFM2 and neoplasm: Small molecule compounds (such as elastin and RSL3) currently under development or discovery mainly target the classic System Xc antioxidant system of tumor cell ferroptosis, with a future focus on other non-classical systems such as FSP1-CoQH2 and the regulation of immune cell death in the tumor microenvironment.